Age-related macular degeneration and antioxidant status in the POLA study

Archives of Ophthalmology

Volumn 117, Issue 10, 1999, Pages 1384-1390

  Delcourt, Cécile ^a   Cristol, Jean Paul ^b   Tessier, Frédéric ^c   Léger, Claude L ^b   Descomps, Bernard ^b   Papoz, Laure ^a  

^a INSERM   (France)

^b Laboratoire de Biologie et Biochimie des Lipides   (France)

^c AGROPARISTECH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; GLUTATHIONE; RETINOL;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; EYE PHOTOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRIENT; PRIORITY JOURNAL; PROTECTION; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR;

EID: 0033391704     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.117.10.1384     Document Type: Article

References (44)

1. Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. 1995;36:182-191.
2. Macular photocoagulation study group. Laser photocoagulation tor juxtafoveal choroidal neovascularization: five-year results from randomized clinical trials. Arch Ophthalmol. 1994;112:500-509.
3. Allikmets R, Shroyer NF, Singh N, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science. 1997;277:1805-1807.
4. Heiba IM, Elston RC, Klein BE, Klein R. Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol. 1994; 11:51-67.
5. Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA. 1996; 276:1141-1146.
6. Vingerling JR, Dielemans I, Bots ML, et al. Age-related macular degeneration is associated with atherosclerosis: the Rotterdam Study. Am J Epidemiol. 1995; 142:404-409.
7. Gerster H. Review: antioxidant protection of the ageing macula. Age Ageing. 1991; 20:60-69.
8. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO. Factors associated with age-related macular degeneration: an analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol. 1988;128:700-710.
9. West S, Vitale S, Hallfrisch J, et al. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol. 1994;112:222-227.
10. Mares-Perlman JA, Klein R, Klein BE, et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol. 1996;114:991-997.
11. Mares-Perlman JA, Brady WE, Klein R, et al. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol. 1995;113:1518-1523.
12. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration: the Eye Disease Case-Control Study Group. JAMA. 1994;272:1413-1420.
13. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol. 1993;111:104-109.
14. Chylack Lt JR, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III: the longitudinal study of Cataract Study Group. Arch Ophthalmol. 1993; 111:831-836.
15. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration: the International ARM Epidemiological Study Group. Sun Ophthalmol. 1995;39: 367-374.
16. Klein R, Davis MD, Magli YL, et al. The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology. 1991;98:1128-1134.
17. Catignani GL, Bieri JG. Simultaneous determination of retinol and α-tocopherol in serum or plasma by liquid chromatography. Clin Chem. 1983; 29:708-712.
18. Tessier F, Birlouez-Aragon I. Validation of micromethod for determining oxidized and reduced vitamin C in plasma by HPLC-fluorescence. Int J Vitam Nutr fles. 1996;66:166-170.
19. Horwitt MK, Harvey CC, Dahm CH, Scarey MT. Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. Ann N Y Acad Sci. 1972;203:223-235.
20. Thurnham DI, Davies JA, Crump BJ, Situnayake RD, Davis M. The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status. Ann Clin Biochem. 1986;23:514-520.
21. Von Herbay A, de Groot H, Hegi U, et al. Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatol. 1994;20:41-46.
22. Sokol RJ, Balistreri WF, Hoofnagle JH, Jones EA. Vitamin E deficiency in adults with chronic liver disease. Am J Clin Nutr. 1985;41:66-72.
23. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ichemic heart disease in cross-cultural epidemiology. Am J Clin Nutr. 1991;53(suppl):326S-334S.
24. Jordan P, Brubacher D, Moser U, Stahelin HB, Gey KF. Vitamin E and vitamin A concentrations in plasma adjusted for cholesterol and triglycerides by multiple regression. Clin Chem. 1995;41:924-927.
25. Traber MG. Biokinetics of vitamin E. In: Cadenas E, Packer L, eds. Handbook of Antioxidants. New York, NY: Marcel Dekker Inc; 1996:43-61.
26. Sokol RJ, Heubl JE, Jannaccone ST, Bove KE, Balistreri WF. Vitamin E deficiency with normal serum vitamin E concentrations in children with chronic cholestasis. N Engl J Med. 1984;310:1209-1212.
27. Refat M, Moore TJ, Kazui M, et al. Utility of breath ethane as a noninvasive biomarker of vitamin E status in children. Pediatr Res. 1991;30:396-403.
28. Sanders TA, Haines AP, Wormald R, Wright LA, Obeid O. Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related macular degeneration and matched control subjects. Am J Clin Nutr. 1993;57:428-433.
29. Smith W, Mitchell P, Rochester C. Serum beta carotene, alpha tocopherol, and age-related maculopathy: the Blue Mountains Eye Study. Am J Ophthalmol. 1997; 124:838-840.
30. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BEK, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol. 1998;148:204-214.
31. Willett WC, Stampfer MJ, Underwood BA, et al. Validation of a dietary questionnaire with plasma carotenoid and α-tocopherol levels. Am J Clin Nutr. 1983;38: 631-639.
32. Gascon-Vila P, Garcia-Closas R, Serra-Majem L, et al. Determinants of the nutritional status of vitamin E in a non-smoking Mediterranean population: analysis of the effect of vitamin E intake, alcohol consumption and body mass index on the serum alpha-tocopherol concentration. Eur J Clin Nutr. 1997;51:723-728.
33. Jacques PF, Halpner AD, Blumberg JB. Influence of combined antioxidant nutrient intakes on their plasma concentrations in an elderly population. Am J Clin Nutr. 1995;62:1228-1233.
34. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99:933-943.
35. Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol. 1989;107:847-852.
36. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology. 1995;102:1450-1460.
37. Price JF, Fowkes FGR. Antioxidant vitamins in the prevention of cardiovascular disease: the epidemiological evidence. Eur Heart J. 1997;18:719-727.
38. Gey KF. Ten-year retrospective on the antioxidant hypothesis of arteriosclerosis: threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk. J Nutr Biochem. 1995;6:206-236.
39. Delcourt C, Diaz JL, Ponton-Sanchez A, Papoz L, and the POLA Study Group. Smoking and age-related macular degeneration: the POLA study. Arch Ophthalmol. 1998;116:1031-1035.
40. Eye Disease Case-Control Study Goup. Risk factors for neovascular age-related macular degeneration: the Eye Disease Case-Control Study Group. Arch Ophthalmol. 1992;110:1701-1708.
41. Vinding T, Appleyard M, Nyboe J, Jensen G. Risk factor analysis for atrophic and exudative age-related macular degeneration: an epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh). 1992;70:66-72.
42. Klein R, Klein BE, Linton KL, Demets DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol. 1993;137:190-200.
43. Vingerling JR, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration and smoking: the Rotterdam Study. Arch Ophthalmol. 1996;114:1193-1196.
44. Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol. 1996;114:1518-1523.